Webinar: Medetomidine

What to know

  • CDC’s Division of Overdose Prevention hosted a webinar on the clinical and public health implications of medetomidine-involved opioid overdose and withdrawal.
  • A recording of the webinar is available.
  • Continuing education is free at CDC TRAIN.

CDC Webinar: Clinical Implications of Medetomidine Mixed with Opioids 

Learn lessons from the field about the diagnosis and treatment of overdoses and withdrawal involving medetomidine mixed with opioids. Medetomidine is an emerging public health problem, and clinicians and public health agencies need to be aware of how shifts in the drug supply over time, such as the addition of adulterants like medetomidine, might change patient signs, symptoms, and management during opioid overdose or withdrawal.

Watch the Webinar at https://youtube.com/live/QuOHI3F4R0I?feature=share

Continuing Education

To receive continuing education (CE) visit CDC TRAIN and search for the course in the Course Catalog using course number WC4994/WD4994 (WD4994 after 9/5/2025)-Medetomidine mixed with opioids: the spectrum of clinical and public health implications from overdose to withdrawal (WD4994 after 9/5/2025). WC4994 After Accreditation Document and WD4994 After Accreditation Document

The registration code is in the video.

Instructions for Obtaining Continuing Education (CE)

Please visit CDC TRAIN and search for the course in the Course Catalog using WC4994/WD4994 (WD4994 after 9/5/2025). Follow the steps below by 09/05/2027.

  1. Register for and complete the course.
  2. Pass the post-assessment at 75%.
  3. Complete the evaluation.
  4. Visit Your Learning to access your certificates and transcript.

FEES: No fees are charged for CDC's CE activities.

Speakers

Allison Arwady, MD, MPH, Director, National Center for Injury Prevention and Control, CDC

Ann M. Sheehy, MD, MS, Chief Medical Officer and Director, Office of Planning, Analysis and Evaluation, Health Resources and Services Administration (HRSA)

Samantha Huo, MD; sharing her experience as Medical Director of the Addiction Consult team at Penn Presbyterian Medical Center, University of Pennsylvania.

Jeanmarie Perrone, MD; Professor of Emergency Medicine; Director, Medical Toxicology and Addiction Medicine Initiatives; and Director, Center for Addiction Medicine and Policy, University of Pennsylvania

Print
Content Source:
National Center for Injury Prevention and Control